ADAG ▲ +0.6% - Adagene Inc. $ADAG - Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates Adagene achieved a development milestone in its collaboration with Exelixis on SAFEbody® antibody-drug conjugate candidates, moving the stock up 0.6% today. Milestone achievements in drug development partnerships typically signal progress toward potential future revenue and validate the platform technology underlying the collaboration. 09-SEP-2026 08:00 AM ET